Search

everythinglearnresearchcommunity

for

Search:↓

Stopping certain drugs can improve skin conditions, arsenicosis affects over half of a Bangladeshi village, males are more vulnerable, and certain treatments are effective for warts, acne, and psoriasis. Smoking and drinking are linked to psoriasis in men, a cream helps with a type of skin cancer, and low iron levels don't directly cause chronic hair loss in women.

High blood pressure drugs often cause skin lupus, stopping the drug usually helps. A vaccine helps prevent genital herpes and HPV-16. More frequent light therapy clears psoriasis faster. No link was found between low iron and chronic hair loss.

Skin problems are common in Bangladesh due to arsenic, prompt treatment of diabetic foot ulcers is crucial, maternal transmission causes most neonatal herpes, treatments for pediatric vasculitis are effective, the chickenpox vaccine works, more frequent UVB therapy helps psoriasis, certain jobs increase hand dermatitis risk, monoclonal antibodies treat psoriasis well, lifestyle affects psoriasis, alefacept improves psoriasis, imiquimod cream partially clears basal cell carcinoma, and iron may not help chronic hair loss.

Blood pressure drugs can cause skin lupus, but it improves after stopping the drug. The glycoprotein D vaccine works against genital herpes in some women, and the HPV-16 vaccine reduces HPV-16 infection and related diseases. More frequent light therapy clears psoriasis faster. A cream called imiquimod effectively treats a type of skin cancer. Iron supplements don't necessarily help with chronic hair loss in women.

Dermal stem cells help regenerate hair follicles and heal skin wounds.

Treatment with plasma rich in growth factors improved hair density and thickness for hair loss patients.

Valproic acid may help hair grow and could be a safe treatment for hair loss.

Micrografts improve hair density and thickness without side effects.

Mouse stem cells from hair follicles can improve wound healing and reduce scarring.

The patch assay can create mature hair follicles from human cells and may help in hair loss treatments.

Early recognition of skin issues in immunocompromised patients is crucial for better outcomes.

Platelet-rich plasma therapy may have benefits and is generally safe, but more research is needed to confirm its effectiveness and safety.

Older age and related diseases increase COVID-19 risk, but anti-aging treatments might help.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

Researchers created hair-inducing human cell clusters using a 3D culture method.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

Human placenta hydrogel helps restore cells needed for hair growth.

Injecting alpha-melanocyte-stimulating hormone in mice improved skin healing and reduced scarring.

Blood stem cells are diverse, influenced by many factors, and understanding them is key for progress in regenerative medicine.

A cat developed skin problems from a certain brand of injected water pills, which went away after switching brands.

Skin health and repair depend on the signals between skin stem cells and their surrounding cells.

PRP injection therapy shows promise for treating hair loss, increasing hair count and thickness with minimal side effects.

The tumor suppressor gene FLCN affects mitochondrial function and energy use in cells.

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

CD19-CAR T cell therapy may help regenerate skin in systemic sclerosis.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Living with lupus as both a patient and doctor improved understanding and care for others.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.